Buy This Fastest Growing Multibagger MNC Pharma Stock For A Target Price Of Rs 5372: ICICI Securities


ICICI Securities in its latest report has given buy rating to the multinational pharmaceutical stock Pfizer Ltd for a target price of Rs 5372 apiece. If investors buy the stock now it has the potential to surge to Rs 5372 with a potential gain of 29%.